Developer docs
API playgroundTry for free, no card

Search company profiles

Cognita

Full company profile

uuid00q4ca3

Namestring
Cognita
Legal namestring
Cognita
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Cognita is a healthcare AI company building generative vision-language models that interpret medical imaging studies in clinical context and produce preliminary reports for radiologist review. Founded in October 2024 by a Stanford-rooted team led by CEO Louis Blankemeier alongside CTO Zhihong Chen and co-founder Akshay Chaudhari, the company focuses initially on radiology because the specialty is already deeply digitized and faces a documented global workforce shortage. Its flagship product, Cognita Chest X-ray (Cognita CXR), is a generative vision-language model that processes chest X-ray images and outputs structured preliminary reports covering demographics, clinical history, prior studies, positive findings, comparisons, and measurements. Internal clinical validation cited by the company showed enhanced detection rates of 16% to 65% for certain significant findings and a potential 18% improvement in interpretation efficiency among participating radiologists. In 2026, Cognita CXR became the first generative vision-language model for radiography to receive FDA Breakthrough Device designation, a development-stage regulatory status that enables prioritized FDA interactions but is not yet a clearance.

The company's business model centers on enterprise B2B deployment of its AI tools directly into radiology workflows within health systems and large radiology practices. Less than a year after founding, Cognita was acquired by Radiology Partners, the world's largest radiology practice, and now operates as the AI business unit of Mosaic Clinical Technologies, a wholly-owned subsidiary of Radiology Partners. This embedded structure gives Cognita access to one of the world's largest real-world radiology datasets for training and validation, continuous human feedback loops from practicing radiologists, clinical infrastructure, and a built-in distribution channel across Radiology Partners' health system footprint. The company is concurrently building an enterprise field sales capability to pursue direct relationships with health systems and hospitals beyond the parent network. Cognita is headquartered in the San Francisco Bay Area, operates as an in-person team of 1-10 employees, and has not disclosed external pricing or external venture funding.

Short descriptiontext

Cognita builds generative vision-language AI models that interpret radiology imaging studies and generate preliminary reports for radiologist review, starting with chest X-rays. It operates as the AI business unit of Radiology Partners, targeting health systems and large radiology practices facing diagnostic workforce shortages.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMenlo Park, United States
HQ citystring
Menlo Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiology AI diagnostics, medical imaging AI, vision-language models, clinical workflow software, radiology interpretation
Industry4 codes
1Radiology AI, CAD & Advanced Visualization Software
CodeHLAHABAJPrimaryYes
2AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
CodeHLACALAGPrimaryNo
3Imaging Informatics & Workflow (PACS/RIS/VNA)
CodeHLAHABAIPrimaryNo
4Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
CodeHLACALADPrimaryNo
NAICS code2 codes
  • Diagnostic Imaging Centers621512
  • Medical Laboratories621511
Product category
Radiology AI Diagnostics
No data
GTM motion2 records

Each record includes

Type, Description, Source

Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Cognita develops generative vision-language AI models that interpret radiology imaging studies in clinical context and generate draft preliminary reports for radiologist review. Its flagship product, Cognita Chest X-ray (Cognita CXR), reads chest X-rays the way a radiologist would, producing comprehensive findings for clinician sign-off. The company operates as the AI business unit of Radiology Partners, the world's largest radiology practice.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Enhanced detection rates of 16% to 65% for certain significant findings in internal clinical validation
+1 more record
Product overview1 text field

Cognita is building healthcare AI, starting with radiology. The company operates as the AI business unit of Mosaic Clinical Technologies (a wholly-owned subsidiary of Radiology Partners). Cognita's primary product is Cognita Chest X-ray (Cognita CXR), a generative vision-language model for chest X-ray interpretation. This model processes X-ray images and generates comprehensive preliminary text reports to support radiologists in clinical decision-making. The company is currently focused on expanding radiology access through AI-assisted diagnosis.

Product and service1 record
1Cognita Chest X-ray (Cognita CXR)
CategoryRadiology AI Software
Description

A generative vision-language AI model for radiography that interprets chest X-rays and generates comprehensive preliminary reports integrated into existing radiologist workflows. Internal clinical validation showed enhanced detection rates of 16% to 65% for certain significant findings and a potential 18% improvement in interpretation efficiency among participating radiologists. Designed for radiologists and health systems facing acute workforce shortages.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Qure.ai develops deep-learning models for radiology interpretation across X-ray, CT, and head CT, with strong global deployment including LMICs. It directly competes in AI-generated radiology findings and reporting.

TypeEmerging player
Description

HeartFlow applies AI to cardiac CT to non-invasively assess coronary artery disease. It is comparable to Cognita as a modality-specialized AI for radiology reporting, but focused specifically on cardiology.

TypeDirect peer
Description

DeepHealth is RadNet's AI subsidiary focused on breast and prostate cancer imaging, with broader radiology AI ambitions. As a competitor also backed by a large imaging-services parent, it parallels Cognita's Radiology Partners ownership structure.

TypeBroad incumbent
Description

RadNet is one of the largest outpatient imaging center operators in the US and has built its own AI capability through DeepHealth. It overlaps with Cognita on AI for radiology workflows at scale, though from a services-platform perspective.

TypeBroad incumbent
Description

Tempus AI (which acquired Arterys) combines imaging AI with broader clinical data. It is comparable to Cognita in applying AI to medical imaging interpretation but operates as a broad data-driven precision medicine platform.

TypeDirect peer
Description

Aidoc develops AI-powered clinical decision support for radiology, including triage and detection of acute findings in CT, with broad enterprise deployments. It directly competes with Cognita in AI-driven radiology workflow augmentation.

TypeDirect peer
Description

Annalise.ai builds comprehensive AI for radiology reporting across multiple modalities and findings, similar to Cognita's vision-language approach to generating preliminary reports from imaging studies.

TypeBroad incumbent
Description

Zebra Medical Vision (now part of Nanox) provides broad radiology AI algorithms across multiple modalities and findings. It is comparable to Cognita as an enterprise radiology AI platform with multiple indications.

TypeDirect peer
Description

Viz.ai builds AI for radiology workflows, most notably for stroke detection and care coordination. It directly competes with Cognita on AI-assisted radiology interpretation and integrated clinical workflows.

TypeDirect peer
Description

RapidAI offers AI for neuroimaging and stroke care coordination, focusing on CT and MRI interpretation. It competes with Cognita in AI-driven radiology workflow enhancement for acute care.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cognita

Radiology AI Diagnosticscognita.ai

Cognita builds generative vision-language AI models that interpret radiology imaging studies and generate preliminary reports for radiologist review, starting with chest X-rays. It operates as the AI business unit of Radiology Partners, targeting health systems and large radiology practices facing diagnostic workforce shortages.

What Cognita does

Cognita is a healthcare AI company building generative vision-language models that interpret medical imaging studies in clinical context and produce preliminary reports for radiologist review. Founded in October 2024 by a Stanford-rooted team led by CEO Louis Blankemeier alongside CTO Zhihong Chen and co-founder Akshay Chaudhari, the company focuses initially on radiology because the specialty is already deeply digitized and faces a documented global workforce shortage. Its flagship product, Cognita Chest X-ray (Cognita CXR), is a generative vision-language model that processes chest X-ray images and outputs structured preliminary reports covering demographics, clinical history, prior studies, positive findings, comparisons, and measurements. Internal clinical validation cited by the company showed enhanced detection rates of 16% to 65% for certain significant findings and a potential 18% improvement in interpretation efficiency among participating radiologists. In 2026, Cognita CXR became the first generative vision-language model for radiography to receive FDA Breakthrough Device designation, a development-stage regulatory status that enables prioritized FDA interactions but is not yet a clearance.

The company's business model centers on enterprise B2B deployment of its AI tools directly into radiology workflows within health systems and large radiology practices. Less than a year after founding, Cognita was acquired by Radiology Partners, the world's largest radiology practice, and now operates as the AI business unit of Mosaic Clinical Technologies, a wholly-owned subsidiary of Radiology Partners. This embedded structure gives Cognita access to one of the world's largest real-world radiology datasets for training and validation, continuous human feedback loops from practicing radiologists, clinical infrastructure, and a built-in distribution channel across Radiology Partners' health system footprint. The company is concurrently building an enterprise field sales capability to pursue direct relationships with health systems and hospitals beyond the parent network. Cognita is headquartered in the San Francisco Bay Area, operates as an in-person team of 1-10 employees, and has not disclosed external pricing or external venture funding.

Cognita firmographics

Firmographics
Name
Cognita
Legal name
Cognita
Website
https://cognita.ai
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Cognita builds generative vision-language AI models that interpret radiology imaging studies and generate preliminary reports for radiologist review, starting with chest X-rays. It operates as the AI business unit of Radiology Partners, targeting health systems and large radiology practices facing diagnostic workforce shortages.
Ownership category
akta.pro rank

Cognita industry classification

Industry
Product category
Radiology AI Diagnostics
NAICS
Diagnostic Imaging Centers (621512), Medical Laboratories (621511)
akta.pro primary industry
Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
akta.pro secondary industries
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Imaging Informatics & Workflow (PACS/RIS/VNA) (HLAHABAI), Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD)

Keywords

  • Radiology AI diagnostics
  • Medical imaging AI
  • Vision-language models
  • Clinical workflow software
  • Radiology interpretation

Where Cognita is headquartered

Location

Headquarters

HQ city
Menlo Park
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cognita business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Cognita product offering

Product offering

Core offering

Cognita develops generative vision-language AI models that interpret radiology imaging studies in clinical context and generate draft preliminary reports for radiologist review. Its flagship product, Cognita Chest X-ray (Cognita CXR), reads chest X-rays the way a radiologist would, producing comprehensive findings for clinician sign-off. The company operates as the AI business unit of Radiology Partners, the world's largest radiology practice.

Product overview

Cognita is building healthcare AI, starting with radiology. The company operates as the AI business unit of Mosaic Clinical Technologies (a wholly-owned subsidiary of Radiology Partners). Cognita's primary product is Cognita Chest X-ray (Cognita CXR), a generative vision-language model for chest X-ray interpretation. This model processes X-ray images and generates comprehensive preliminary text reports to support radiologists in clinical decision-making. The company is currently focused on expanding radiology access through AI-assisted diagnosis.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cognita Chest X-ray (Cognita CXR) A generative vision-language AI model for radiography that interprets chest X-rays and generates comprehensive preliminary reports integrated into existing radiologist workflows. Internal clinical validation showed enhanced detection rates of 16% to 65% for certain significant findings and a potential 18% improvement in interpretation efficiency among participating radiologists. Designed for radiologists and health systems facing acute workforce shortages.

Quantifiable outcome

  • Enhanced detection rates of 16% to 65% for certain significant findings in internal clinical validation
  • +1 more outcomes

Companies that use Cognita

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Cognita technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Cognita partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Cognita competitors and assessment

Company assessment

Direct peers

  • Qure.ai: Qure.ai develops deep-learning models for radiology interpretation across X-ray, CT, and head CT, with strong global deployment including LMICs. It directly competes in AI-generated radiology findings and reporting.
  • DeepHealth: DeepHealth is RadNet's AI subsidiary focused on breast and prostate cancer imaging, with broader radiology AI ambitions. As a competitor also backed by a large imaging-services parent, it parallels Cognita's Radiology Partners ownership structure.
  • Aidoc: Aidoc develops AI-powered clinical decision support for radiology, including triage and detection of acute findings in CT, with broad enterprise deployments. It directly competes with Cognita in AI-driven radiology workflow augmentation.
  • Annalise.ai: Annalise.ai builds comprehensive AI for radiology reporting across multiple modalities and findings, similar to Cognita's vision-language approach to generating preliminary reports from imaging studies.
  • Viz.ai: Viz.ai builds AI for radiology workflows, most notably for stroke detection and care coordination. It directly competes with Cognita on AI-assisted radiology interpretation and integrated clinical workflows.
  • RapidAI: RapidAI offers AI for neuroimaging and stroke care coordination, focusing on CT and MRI interpretation. It competes with Cognita in AI-driven radiology workflow enhancement for acute care.

Emerging players

  • HeartFlow: HeartFlow applies AI to cardiac CT to non-invasively assess coronary artery disease. It is comparable to Cognita as a modality-specialized AI for radiology reporting, but focused specifically on cardiology.

Broad incumbents

  • RadNet: RadNet is one of the largest outpatient imaging center operators in the US and has built its own AI capability through DeepHealth. It overlaps with Cognita on AI for radiology workflows at scale, though from a services-platform perspective.
  • Tempus AI: Tempus AI (which acquired Arterys) combines imaging AI with broader clinical data. It is comparable to Cognita in applying AI to medical imaging interpretation but operates as a broad data-driven precision medicine platform.
  • Zebra Medical Vision: Zebra Medical Vision (now part of Nanox) provides broad radiology AI algorithms across multiple modalities and findings. It is comparable to Cognita as an enterprise radiology AI platform with multiple indications.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Cognita compliance and trust

Trust signal

Compliance1 record

Cognita financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cognita leadership team

Management profile

Number of profiles

Profiles8 records

Cognita funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cognita M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cognita

What does Cognita do?

Cognita develops generative vision-language AI models that interpret radiology imaging studies in clinical context and generate draft preliminary reports for radiologist review. Its flagship product, Cognita Chest X-ray (Cognita CXR), reads chest X-rays the way a radiologist would, producing comprehensive findings for clinician sign-off. The company operates as the AI business unit of Radiology Partners, the world's largest radiology practice.

Is Cognita a public or private company?

Cognita is a private company. It is classified as corporate owned and is currently operating.

When was Cognita founded?

Cognita was founded in -1. It employs 1 to 10 people.

Where is Cognita based?

Cognita is headquartered in Menlo Park, United States, in the North America region.

Who are Cognita's main competitors?

Direct peers on record are Qure.ai, DeepHealth, Aidoc, Annalise.ai, Viz.ai and RapidAI. HeartFlow is listed as an emerging player. Broad incumbents are RadNet, Tempus AI and Zebra Medical Vision.

Does Cognita have an API?

No public API is recorded for Cognita.

What industry is Cognita in?

Cognita's product category is Radiology AI Diagnostics. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 621512.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Cognita: Interview With CTO Zhihong Chen About Foundation Models For RadiologyCognita's CTO Zhihong Chen described the company's foundation models that draft comprehensive radiology reports for X-rays and CT scans, with radiologists retaining final control. The company received FDA Breakthrough Device Designation for its chest X-ray generative AI model, and plans to expand beyond radiology to pathology, omics, and EHR data.STATFDA gives generative AI in radiology two breakthrough designation nodsThe Food and Drug Administration has granted breakthrough designation to two devices that use generative AI to interpret chest X-rays and draft radiology reports, representing a significant shift from traditional image analysis to full report generation. Cognita, a Stanford researcher-founded startup acquired by Radiology Partners, received designation in March, while radiology AI company Aidoc announced its designation Thursday for a tool called First Read designed to detect and describe four life-threatening findings. This technological advancement is challenging traditional validation and regulatory frameworks for AI in medical imaging.STATFDA gives generative AI in radiology two breakthrough designation nodsThe FDA granted breakthrough designation to two generative AI devices for chest X-ray interpretation and radiology report drafting. Cognita received the designation in March, and Aidoc's First Read tool was designated Thursday for detecting four life-threatening findings.Business InsiderTeen Is Working Fulltime AI Job While Still at UC BerkeleyAdrit Rao, a freshman at UC Berkeley, landed a full-time position as a technical product lead at AI health company Cognita before ever starting college, after being recruited by CEO Louis Blankemeier via a Slack message. Rao developed his technical skills from age 8, winning Apple's Swift Student Challenge at age 12 as its youngest winner and meeting CEO Tim Cook, later working as a teaching assistant and researcher at Stanford before joining Cognita. He balances his full-time role with early-morning college classes, demonstrating how early passion for technology and mentorship can accelerate career paths.CryptoRankI Sold My Startup A Year After Founding It. Here’s Why That Was The Fastest Way To Build Real-World Healthcare AILouis Blankemeier, co-founder and CEO of Cognita (the AI business unit of Mosaic Clinical Technologies), describes selling his startup to Radiology Partners less than a year after its founding in October 2024, arguing that acquisition provided the scale, clinical infrastructure, regulatory pathways, and continuous human feedback loops required to make radiology AI clinically viable rather than remaining an independent startup. The author contends that healthcare AI success requires massive diverse datasets, operational infrastructure, regulatory clearance, and live clinical workflows that are difficult to achieve outside an established healthcare system. The author argues that selling early accelerated rather than shortened their journey to increasing global access to healthcare through AI.CryptoRankI Sold My Startup A Year After Founding It. Here’s Why That Was The Fastest Way To Build Real-World Healthcare AILouis Blankemeier, CEO and co-founder of Cognita, argues in a personal essay that selling his startup to Radiology Partners less than a year after founding it in October 2024 was the optimal path to advancing real-world healthcare AI. He contends that clinical AI requires massive scale, diverse datasets, operational infrastructure, regulatory clearance, and continuous human feedback loops that are nearly impossible to build as a standalone startup due to healthcare's long sales cycles and complex stakeholder dynamics. Blankemeier concludes that joining the world's largest radiology practice provided the foundation to demonstrate clinical efficacy across diverse settings, accelerating the mission to increase global access to healthcare.AijournMosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for RadiologyMosaic Clinical Technologies, a wholly-owned subsidiary of Radiology Partners, has received FDA Breakthrough Device Designation for Cognita Chest X-Ray, a generative vision-language AI model designed to assist radiologists in interpreting chest X-rays. Internal clinical validation showed enhanced detection rates of 16% to 65% for certain significant findings and a potential 18% improvement in interpretation efficiency among participating radiologists. The designation enables prioritized FDA interactions as the technology advances toward regulatory clearance amid an acute shortage of radiologists in the U.S. healthcare system.MorningstarMosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for RadiologyMosaic Clinical Technologies, a wholly-owned subsidiary of Radiology Partners, has received FDA Breakthrough Device Designation for Cognita Chest X-Ray, an industry-first generative vision-language AI model designed to assist radiologists in interpreting chest X-rays. Internal clinical validation showed that participating radiologists using Cognita CXR achieved enhanced detection of 16–65% for certain significant findings and a potential 18% boost in interpretation efficiency. The designation enables prioritized FDA collaboration as the company advances through the regulatory process to address the acute radiology capacity crisis affecting the U.S. healthcare system.